Survival in Mycosis Fungoides and Sezary Syndrome: How Can We Predict Outcome?
- 1 February 2020
- journal article
- editorial
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 140 (2) , 281-283
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Overall Survival in Mycosis Fungoides: A Systematic Review and Meta-AnalysisJournal of Investigative Dermatology, 2020
- The PROCLIPI international registry of early‐stage mycosis fungoides identifies substantial diagnostic delay in most patientsBritish Journal of Dermatology, 2018
- The Use of Central Pathology Review With Digital Slide Scanning in Advanced-stage Mycosis Fungoides and Sézary SyndromeAmerican Journal of Surgical Pathology, 2018
- Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic ModelJournal of Clinical Oncology, 2015
- A cutaneous lymphoma international prognostic index (CLIPi) for mycosis fungoides and Sezary syndromeEuropean Journal of Cancer, 2013
- Long-term Outcomes of 1,263 Patients with Mycosis Fungoides and Sézary Syndrome from 1982 to 2009Clinical Cancer Research, 2012
- Allogeneic Hematopoietic Cell Transplantation for Patients With Mycosis Fungoides and Sézary Syndrome: A Retrospective Analysis of the Lymphoma Working Party of the European Group for Blood and Marrow TransplantationJournal of Clinical Oncology, 2010
- WHO-EORTC classification for cutaneous lymphomasBlood, 2005
- Prognostic factors in aggressive non-Hodgkin's lymphoma: who has "high- risk" disease?Blood, 1994